openPR Logo

Press Releases from DelveInsight Business Research LLP (4878 total)

Hepatocellular Carcinoma Pipeline Assessment (2023 Updates) | In-depth Insights …

As per DelveInsight's assessment, globally, about 80+ key pharma and biotech companies are working on 80+ pipeline drugs in the Hepatocellular Carcinoma therapeutics landscape based

Prosthetic Joint Infection (PJI) Market to Observe Stunning Growth During the Fo …

As per DelveInsight, the Prosthetic Joint Infection Market size was found to be USD 57.73 million in 2017, which is expected to grow by 2032.

Alcoholic Hepatitis Emerging and Marketed Drugs Assessment (2023 Updates) | Clin …

As per DelveInsight's assessment, globally, about 10+ key pharma and biotech companies are working on 10+ pipeline drugs in the Alcoholic Hepatitis therapeutics landscape based

Von Willebrand Disease Emerging and Marketed Drugs Assessment (2023 Updates) | C …

As per DelveInsight's assessment, globally, several major key pharma and biotech companies are actively working in the Von Willebrand Disease therapeutics landscape based on different

Human Papillomavirus (HPV) Market to Observe Stupendous Growth During the Foreca …

As per DelveInsight, the Human Papillomavirus (HPV) Market is anticipated to evolve immensely in the coming years owing to the launch of upcoming therapies, the

Systemic Lupus Erythematosus (SLE) Market to Register Incremental Growth During …

As per DelveInsight, the Systemic Lupus Erythematosus Market is anticipated to evolve immensely in the coming years owing to the expected launch of emerging therapies

Recessive Dystrophic Epidermolysis Emerging and Marketed Drugs Assessment (2023 …

As per DelveInsight's assessment, globally, about 7+ key pharma and biotech companies are working on 7+ pipeline drugs in the Recessive Dystrophic Epidermolysis therapeutics landscape

Becker Muscular Dystrophy Emerging and Marketed Drugs Assessment (2023 Updates) …

As per DelveInsight's assessment, globally, about 8+ key pharma and biotech companies are working on 8+ pipeline drugs in the Becker Muscular Dystrophy therapeutics landscape

Cone Rod Dystrophy Emerging and Marketed Drugs Assessment (2023 Updates) | Clini …

The Cone Rod Dystrophy therapeutics market is anticipated to evolve immensely in the coming years owing to the increasing prevalent population of Cone rod dystrophies

Chronic Lymphocytic Leukemia Emerging and Marketed Drugs Assessment (2023 Update …

As per DelveInsight's assessment, about 60+ key pharma and biotech companies are working on 60+ pipeline drugs in the Chronic Lymphocytic Leukemia therapeutics landscape based

Epidermolysis Bullosa Emerging and Marketed Drugs Assessment (2023 Updates) | Cl …

As per DelveInsight's assessment, globally, about 20+ key pharma and biotech companies are working on 25+ pipeline drugs in the Epidermolysis Bullosa therapeutics landscape

MELAS Syndrome Market is Predicted to Exhibit Remarkable Growth During the Forec …

As per DelveInsight, the MELAS Syndrome Market is anticipated to evolve immensely in the coming years owing to the increase in the prevalence of MELAS

Homozygous Familial Hypercholesterolemia (HoFH) Market to Observe Stupendous Gro …

As per DelveInsight, the Homozygous Familial Hypercholesterolemia Market is expected to grow in the coming years owing to the rise in the number of prevalent

Duchenne Muscular Dystrophy (DMD) Market to Register Incremental Growth During t …

As per DelveInsight, the Duchenne Muscular Dystrophy Market is anticipated to evolve immensely in the coming years owing to the increase in the diagnosed prevalent

Pseudomonal Infections Emerging and Marketed Drugs Assessment (2023 Updates) | C …

As per DelveInsight's assessment, globally, about 15+ key pharma and biotech companies are working on 15+ pipeline drugs in the Pseudomonal Infections therapeutics landscape based

Primary Sclerosing Cholangitis Emerging and Marketed Drugs Assessment (2023 Upda …

As per DelveInsight's assessment, globally, about 14+ key pharma and biotech companies are working on 14+ pipeline drugs in the Primary Sclerosing Cholangitis therapeutics landscape

Fragile X Syndrome Emerging and Marketed Drugs Assessment (2023 Updates) | Clini …

As per DelveInsight's assessment, about 20+ key pharma and biotech companies are working on 22+ pipeline drugs in the Fragile X Syndrome therapeutics landscape based

Thyroid Cancer Emerging and Marketed Drugs Assessment (2023 Updates) | Clinical …

As per DelveInsight's assessment, about 40+ key pharma and biotech companies are working on 40+ pipeline drugs in the Thyroid Cancer therapeutics landscape based on

IPSC derived NK Cells Emerging and Marketed Drugs Assessment (2023 Updates) | Cl …

As per DelveInsight's assessment, about 15+ prominent pharma and biotech giants are working on 30+ drugs in the IPSC derived NK Cells pipeline landscape globally. "IPSC

Genital Herpes Emerging and Marketed Drugs Assessment (2023 Updates) | Clinical …

As per DelveInsight's assessment, about 26+ key pharma and biotech companies are working on 28+ pipeline drugs in the Genital Herpes therapeutics landscape based on

Pancreatic Cancer Emerging and Marketed Drugs Assessment (2023 Updates) | Clinic …

As per DelveInsight's assessment, globally, about 120+ key pharma and biotech companies are working on 150+ pipeline drugs in the Pancreatic Cancer therapeutics landscape based

Cryopyrin-Associated Periodic Syndrome (CAPS) Market to Exhibit Substantial Grow …

As per DelveInsight, the Cryopyrin-Associated Periodic Syndrome therapeutics market is anticipated to grow immensely in the coming years owing to the expected improvement in the

Collagen Inhibitors Pipeline Development Activities | Insights Into the Clinical …

As per DelveInsight's assessment, about 10+ prominent pharma and biotech giants are working on 10+ drugs in the Collagen Inhibitors pipeline landscape globally. "Collagen Inhibitors Pipeline

Transforming Growth Factor Beta (TGFb) Inhibitor Pipeline Development Activities …

As per DelveInsight's assessment, about 90+ prominent pharma and biotech giants are working on 90+ drugs in the Transforming Growth Factor Beta (TGFb) Inhibitor pipeline

Shingles Emerging and Marketed Drugs Assessment (2023 Updates) | Clinical and No …

"Shingles Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Shingles Therapeutics Market.

Severe Hypoglycemia Emerging and Marketed Drugs Assessment (2023 Updates) | Clin …

As per DelveInsight's assessment, about 30+ key pharma and biotech companies are working on 30+ pipeline drugs in the Severe Hypoglycemia therapeutics landscape based on

Uncomplicated Urinary Tract Infections Emerging and Marketed Drugs Assessment (2 …

"Uncomplicated Urinary Tract Infections Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the

Triple Negative Breast Cancer Emerging and Marketed Drugs Assessment (2023 Updat …

As per DelveInsight, the Triple Negative Breast Cancer therapeutics market is anticipated to evolve immensely in the coming years owing to the increasing incident population

Therapy Resistant Psychiatric Disorders Emerging and Marketed Drugs Assessment ( …

As per DelveInsight, the Therapy Resistant Psychiatric Disorders therapeutics market is anticipated to evolve immensely in the coming years owing to the increased awareness of

T-cell Malignancies Emerging and Marketed Drugs Assessment (2023 Updates) | Clin …

As per DelveInsight, the T-cell Malignancies therapeutics market is anticipated to evolve immensely in the coming years owing to the increase in the number of

Squamous Cell Carcinoma of the Lung Emerging and Marketed Drugs Assessment (2023 …

"Squamous Cell Carcinoma of the Lung Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects

Single Ventricle Heart Disease Emerging and Marketed Drugs Assessment (2023 Upda …

As per DelveInsight, the Single Ventricle Heart Disease market is anticipated to evolve immensely in the coming years owing to the rise in the prevalent

Parkinson's Disease Treatment-Resistant Epilepsy Emerging and Marketed Drugs Ass …

The current understanding of Parkinson's Disease Treatment-Resistant Epilepsy has greatly improved in recent decades, leading to growing awareness, improved management, and better outcomes. As per

Overt Hepatic Encephalopathy Emerging Pipeline and Marketed Drugs Assessment | C …

As per DelveInsight, the Overt Hepatic Encephalopathy therapeutics market is anticipated to evolve immensely in the coming years owing to the expected approval of emerging

Neurotrophic Keratitis Emerging Pipeline and Marketed Drugs Assessment | Clinica …

As per DelveInsight, the Neurotrophic Keratitis therapeutics market is anticipated to evolve immensely in the coming years owing to the expected launch of potential therapies

Neuropathic Pain Emerging Pipeline and Marketed Drugs Assessment | Clinical Tria …

As per DelveInsight, Neuropathic Pain is anticipated to evolve immensely in the coming years owing to the launch of upcoming therapies, the rise in healthcare

Musculoskeletal Pain Emerging Pipeline and Marketed Drugs Assessment | Clinical …

As per DelveInsight, the Musculoskeletal Pain therapeutics market is anticipated to evolve immensely in the coming years owing to the increasing healthcare expenditure, rise in

Moderate and Severe Chronic Kidney Disease Emerging Pipeline Drugs Assessment | …

As per DelveInsight's assessment, about 50+ key pharma and biotech companies are working on 50+ pipeline drugs in the Moderate and Severe Chronic Kidney Disease

Mild Cognitive Impairment Marketed and Emerging Pipeline Drugs Assessment | Clin …

As per DelveInsight's assessment, several major key pharma and biotech companies are working on various pipeline drugs in the Mild Cognitive Impairment therapeutics landscape based

Infantile Spasms Market to Witness Growth by 2032, Estimates DelveInsight

DelveInsight's "Infantile Spasms Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Infantile Spasms, historical and forecasted epidemiology as well as the

Blepharitis Market to Witness Growth by 2032, Estimates DelveInsight

DelveInsight's "Blepharitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Blepharitis Market, historical and forecasted epidemiology as well as the Blepharitis

Narcolepsy Market to Witness Growth by 2032, Estimates DelveInsight

DelveInsight's "Narcolepsy Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Narcolepsy, historical and forecasted epidemiology, and the Narcolepsy market trends in

Idiopathic Short Stature Market to Witness Growth by 2032, Estimates DelveInsigh …

DelveInsight's "Idiopathic Short Stature Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Idiopathic Short Stature, historical and forecasted epidemiology as well

Female infertility Market to Witness Growth by 2032, Estimates DelveInsight

DelveInsight's "Female infertility Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Female infertility, historical and forecasted epidemiology as well as the

Cryoglobulinemia Market to Witness Growth by 2032, Estimates DelveInsight

DelveInsight's "Cryoglobulinemia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Cryoglobulinemia , historical and forecasted epidemiology as well as the Cryoglobulinemia

Dementia Market to Witness Growth by 2032, Estimates DelveInsight

DelveInsight's "Dementia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Dementia, historical and forecasted epidemiology as well as the Dementia market

Noonan Syndrome Market to Witness Growth by 2032, Estimates DelveInsight

DelveInsight's "Noonan Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Noonan Syndrome, historical and forecasted epidemiology as well as the

Cryopyrin-associated Periodic Syndrome Market to Witness Growth by 2032, Estimat …

DelveInsight's "Cryopyrin-associated Periodic Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Cryopyrin-associated Periodic Syndrome , historical and forecasted epidemiology as

Chronic Spontaneous Urticaria (CSU) Market to Witness Growth by 2032, Estimates …

DelveInsight's "Chronic Spontaneous Urticaria (CSU) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Chronic Spontaneous Urticaria (CSU), historical and forecasted epidemiology

Endometriosis Market to Witness Growth by 2032, Estimates DelveInsight

Endometriosis Market to Witness Growth by 2032, Estimates DelveInsight DelveInsight's "Endometriosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Endometriosis, historical and

Go To Page:    91 92 93 94 95 96 97